TGFB1 and neoplasm: These findings and the previous reports together confirm that CSCs evade immune-attack by converting anti-tumor T cells to pro-tumor Treg cells via generation of immune-suppressive cytokine TGFβ, to initiate tumor either at the primary site or during tumor recurrence following withdrawal of chemotherapy.